<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We have shown previously that stromal genetic alteration may make a greater contribution to early genesis of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> than <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:hpo ids='HP_0003003'>colon cancers</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We assessed whether similar differences in genetic alteration might exist between <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> (<z:mp ids='MP_0004207'>SCCs</z:mp>) and Barrett's <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (BACs) of the esophagus </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We investigated epithelial and stromal genetic instability with five National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Institute standard (NCI), four chromosome 17 (Chr </plain></SENT>
<SENT sid="3" pm="."><plain>17), and six <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene (TSG) microsatellite markers in 26 <z:mp ids='MP_0004207'>SCC</z:mp> and 12 BAC cases and in 11 <z:mpath ids='MPATH_458'>normal</z:mpath> controls, using a novel combination of microdissection, polymerase chain reaction, and GeneScan </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Frequency of epithelial loss of heterozygosity (LOH) increased in the order background mucosa, to precursor lesions, to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with both types of <z:mp ids='MP_0002038'>carcinoma</z:mp>, especially for the Chr </plain></SENT>
<SENT sid="5" pm="."><plain>17 and TSG markers, while stromal LOH was relatively high but consistent from background mucosa to <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Epithelial LOH of D17S796 demonstrated a significantly higher frequency in <z:mp ids='MP_0004207'>SCCs</z:mp> than in BACs, without significant variation in p53 overexpression </plain></SENT>
<SENT sid="7" pm="."><plain>The frequency of microsatellite instability (MSI) showed constant high levels in both epithelium and stroma of background, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:mp ids='MP_0002038'>carcinomas</z:mp> in the <z:mp ids='MP_0004207'>SCC</z:mp> series, and rather low frequencies in the BAC series </plain></SENT>
<SENT sid="8" pm="."><plain>Although epithelial hMLH1 and hMSH2 expression decreased with <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e>, no correlation was found with the individual MSI status </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Although epithelial LOH exists similarly in both lesion types, whereas epithelial and stromal MSI may occur in a relatively early phase of <z:mp ids='MP_0004207'>SCC</z:mp> development, stromal MSI is rare in BACs, strongly suggesting differences in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> between the two types </plain></SENT>
</text></document>